Abstract
Bioequivalence between two treatments or two drugs is often assessed by comparing the two proportions (success rate or eradication rate) of binomial outcomes when the conventional pharmacokinetic parameters are inadequate for the assessment. Setting the equivalence limits can be based on one of the three measures: difference, ratio, or odds ratio between the two binomial probabilities. This paper reviews the existing asymptotic test statistics for comparing two independent binomial probabilities in terms of the three measures in the context of equivalence or noninferiority testing. The actual type I error and power of the asymptotic tests are evaluated by enumerating the exact probabilities in the rejection region. The results show that to establish an equivalence between two treatments with an equivalence limit of 20% in difference, a sample size of at least 50 per treatment is needed. When the sample size is sufficient, the actual type I error rate is close to the nominal level (slightly above the nominal level in several cases) for a test in terms of difference for equivalence limits, and it tends to exceed the nominal level for tests in terms of ratio or odds ratio.
Similar content being viewed by others
References
Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker; 1992.
FDA. Guidance on statistical procedure for bioequivalence studies using a standard two-treatment crossover design. Rockville, MD: Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1992.
FDA. Guidance—Topical Dermatologic Corticosteroids: In vivo bioequivalence. Rockville, MD: Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; 1995.
Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharm Biopharm 1987;15:657–680.
Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat Sci 1996;11:283–318.
Rodary C, Com-Nougue C, Tournade M. How to establish equivalence between treatments: a onesided clinical trial in pediatric oncology. Stat Med 1989;8:593–598.
Dunnett CW, Gent M. Significance testing to establish equivalence between treatments with special reference to data in the form of 2 × 2 tables. Biometrics 1977;33:593–602.
Huque MF, Dubey S. Design and analysis for therapeutic equivalence clinical trials with binary clinical endpoints. The 1990 Proceedings of the Biopharmaceutical Section of the American Statistical Association. 1990;91–98.
Blackwelder WC. Proving the null hypothesis in clinical trials. Control Clin Trials 1982;3:345–353.
Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or no-nunity relative risk. Stat Med 1990;9:1447–1454.
Tu D. A comparative study of some statistical procedures in establishing therapeutic equivalence of non-systemic drugs with binary endpoints. Drug Inf J 1997;31:1291–1300.
Agresti A. Categorical Data Analysis. New York: John Wiley & Sons; 1990.
O’Neill RT. On the sample sizes to estimate the protective efficacy of vaccine. Stat Med 1988;7:1279–1288.
Thomas DG, Gart JJ. A table of exact confidence limits for differences and ratios of two proportions ad their odds ratios. J Am Stat Assoc 1977;72:73–76.
Lehmann EL. Testing Statistical Hypothesis, 2nd ed. New York: Wiley; 1986.
Agresti A. A Survey of Exact Inference for Contingency Tables. Stat Sci 1992;7:131–177.
Fisher RA. The logic of inductive inference. J Royal Stat Society, Series A 1935;98:39–54.
Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics 1984;40:819–825.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, J.J., Tsong, Y. & Kang, SH. Tests for Equivalence or Noninferiority Between Two Proportions. Ther Innov Regul Sci 34, 569–578 (2000). https://doi.org/10.1177/009286150003400225
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286150003400225